Testosterone Cyp 200 mg/mL Sesame Inj — Class II drug recall D-0264-2015
Terminated recall by Perry Drug Inc., reported 2014-12-03, distributed in KS, MO. Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry wer
| Recall number | D-0264-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Perry Drug Inc., Overland Park, KS, United States |
| Recall initiated | 2014-11-07 |
| Classified | 2014-11-24 |
| Reported by FDA | 2014-12-03 |
| Terminated | 2015-11-03 |
| Distributed | KS, MO |
| Quantity | 1 vials |
| Reason classes | sterility |
| NDC | 88888-7906-71 |
Product
Testosterone Cyp 200 mg/mL Sesame Inj., 4Ml Syringes, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-7906-71
Reason for recall
Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0264-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.